Department of Cardiology, Hamad Medical Corporation, Qatar.
J Cardiol. 2011 Mar;57(2):165-71. doi: 10.1016/j.jjcc.2010.11.008. Epub 2011 Jan 15.
Patients with acute coronary syndrome (ACS) frequently present with typical chest pain; however a considerable proportion may present with atypical symptoms.
The purpose of this study was to evaluate the prognostic value of different presenting symptoms in ACS patients.
Over a 5-month period in 2007, 6704 consecutive patients presenting with ACS were enrolled and categorized into three groups according to their presenting symptom (typical chest pain, atypical chest pain, and dyspnea). Data were collected from a prospective, multicenter, multinational, observational study from 6 countries. The baseline characteristics, therapy, and in-hospital outcomes were analyzed and compared in the three groups.
In comparison to typical chest pain, patients with atypical pain or dyspnea were older and had more cardiovascular risk factors. These two groups were significantly less likely to receive evidence-based therapy and coronary angiography and suffered worse in-hospital outcomes. The mortality rates were 3%, 2.5%, and 6% in patients presenting with typical, atypical chest pain, and dyspnea, respectively. After adjustment for confounders, the absence of typical chest pain was associated with higher mortality rate (odds ratio 2.0, 95% confidence intervals 1.29-2.75).
Across ACS, patients presenting without chest pain were frequently underestimated, less well treated with evidence-based therapy, and had worse in-hospital outcomes. Clinical presentation of ACS may provide additional prognostic impact particularly in high-risk populations.
急性冠状动脉综合征(ACS)患者常表现为典型胸痛,但相当一部分患者可能表现为不典型症状。
本研究旨在评估 ACS 患者不同首发症状的预后价值。
2007 年 5 个月期间,纳入了 6704 例连续出现 ACS 的患者,并根据首发症状(典型胸痛、非典型胸痛和呼吸困难)将其分为三组。数据来自 6 个国家的前瞻性、多中心、多国观察性研究。分析并比较了三组的基线特征、治疗和住院结局。
与典型胸痛相比,非典型胸痛或呼吸困难患者年龄更大,且有更多心血管危险因素。这两组患者接受基于证据的治疗和冠状动脉造影的可能性显著降低,住院结局更差。典型胸痛、非典型胸痛和呼吸困难患者的死亡率分别为 3%、2.5%和 6%。在调整混杂因素后,无典型胸痛与更高的死亡率相关(比值比 2.0,95%置信区间 1.29-2.75)。
在 ACS 中,无胸痛表现的患者常被低估,接受基于证据的治疗的可能性较小,住院结局较差。ACS 的临床表现可能提供额外的预后影响,尤其是在高危人群中。